Prothena Corp. Plc (PRTA)
11.10
+0.23
(+2.12%)
USD |
NASDAQ |
Apr 30, 15:52
Prothena Market Cap : 597.55M for April 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 188.05B |
| Jazz Pharmaceuticals Plc | 12.50B |
| Amarin Corp. Plc | 290.22M |
| Iterum Therapeutics Plc | 0.4466M |
| GH Research Plc | 1.256B |
Market Cap Related Metrics
| PS Ratio | 61.70 |
| PEG Ratio | -0.0253 |
| Price to Book Value | 2.130 |
| Price | 11.10 |
| Earnings Yield | -40.85% |
| PEGY Ratio | -0.0253 |